(San Francisco, CA) The California Institute for Regenerative Medicine (CIRM) awarded $60 million to researchers hoping to accelerate the development of a treatment for type I diabetes....
(Tokyo, Japan) The non-life insurance companies in Japan will begin to sell policies to cover the cultivation of stem cells for regenerative medicine procedures....
(San Francisco, CA) The University of California, San Francisco announced that it has entered into an exclusive license agreement with Accurexa, Inc for global licensing of a medical stereotactic...
(Alameda, CA) BioTime Inc. completed a series of extensive preclinical safety and efficacy studies for its product OpRegen intended for treatment of dry age-related macular degeneration....
(Haifa, Israel) Pluristem Therapeutics Inc. a leading developer of placenta-based cell therapy products is evaluating strategic opportunities to co-develop and commercialize cell therapy products in Japan....
(Washington, DC) Global competition with a $1 million prize for the first team to create a bioengineered solution to survive without native liver function....